Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

12 results about "Breast cancer" patented technology

A cancer that develops in the breast cells and progresses in stages.

Thioredoxin reductase inhibiter compounds and preparation method and application thereof

ActiveCN101781283AOrganic chemistryAntineoplastic agentsMelanomaProstate cancer
The invention discloses thioredoxin reductase inhibiter compounds, which have antitumor activity, particularly have growth inhibition activity for solid tumor, wherein the solid tumor is thyroid cancer, prostatic cancer, colon cancer, rectal cancer, melanoma, liver cancer, lung cancer, gastric cancer, carcinoma submaxilary gland, nasopharyngeal darcinoma or breast cancer.
Owner:KEAISE MEDICINE WUHAN

Nano-vesicles derived from genus cupriavidus bacteria and use thereof

InactiveUS20190390284A1Inhibition of secretionNervous disorderNanomedicineProstate cancerObstructive Pulmonary Diseases
Provided are vesicles derived from bacteria belonging to the genus Cupriavidus, a composition and a use thereof, wherein the vesicles or composition may be usefully used for the purpose of developing a method of diagnosing a malignant diseases such as gastric cancer, colon cancer, pancreatic cancer, cholangiocarcinoma, breast cancer, ovarian cancer, bladder cancer, prostate cancer, head and neck cancer, lymphoma, and the like, heart diseases such as cardiomyopathy, atrial fibrillation, variant angina, and the like, chronic obstructive pulmonary disease, stroke, diabetes, kidney failure, dementia, Parkinson's disease, or depression.
Owner:MD HEALTHCARE INC

Lung cancer and breast cancer treatment compound preparation containing active ingredients of traditional Chinese medicine and preparation method of lung cancer and breast cancer compound preparation

InactiveCN105079005AGood inhibitory effectHigh anticancer activityEther/acetal active ingredientsRespiratory disorderPolyethylene glycolIn vivo
The invention discloses a lung cancer and breast cancer treatment compound preparation containing active ingredients of traditional Chinese medicine and a preparation method of the lung cancer and breast cancer compound preparation. The lung cancer and breast cancer treatment compound preparation is made from erianin, taxol, bufalin and bruceine D according to a certain weight ratio. According to the preparation method, liposomes are prepared according to an ethyl alcohol injection method or dropping pills are prepared by taking polyethylene glycol as a base material to obtain the lung cancer and breast cancer treatment compound preparation containing the active ingredients of the traditional Chinese medicine. The form of the compound preparation is compound liposomes and compound dripping pills. According to animal in-vivo anticancer pharmacological experiments, the lung cancer and breast cancer treatment compound preparation containing the active ingredients of the traditional Chinese medicine has obvious inhibiting effect on growth of lung cancer and breast cancer and has higher anticancer activity than chemotherapeutic drug 5-fluorouracil.
Owner:NANJING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE

Saponins antineoplastic compound in Bohadschia argus Jaeger

InactiveCN101085805AOrganic active ingredientsSteroidsChemical structureResource utilization
The invention relates to medical technique, which in detail relates to a saponin antineoplastic compound Arguside B or Arguside C. The R1 in structure general formula represents OH or H, R2 represents CH3 or CH2OH, when R1 is OH and R2 is CH3, the compound is Arguside B; when R1 is H and R2 is CH2OH, the compound is Arguside C. The chemical structure and spatial configuration of said two compounds are determined through various modern spectral analysises, especially through analysis with multiple advanced nuclear magnetic resonance spectroscopy. It is tested that said two compounds are apparently inhibitive to seven cancers such as A- 549 lung cancer and MCF- 7 breast cancer. It can be used to prepare antineoplastic medicine. The invention provides leading compound for new antineoplastic medicine development, and is valuable for ocean biological resource utilization in China.
Owner:SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY

Antibodies specific for cancer associated antigen SM5-1 and uses thereof

InactiveUS20050232926A1Animal cellsIn-vivo radioactive preparationsAntigenMelanoma
The invention concerns antibodies which is specific for SM5-1 antigen expressed in melanoma, breast cancer and hepatocellular carcinoma, and polynucleotides encoding the antibodies. The invention further concerns use of such antibodies and / or polynucleotides in diagnosing and treating malignancies.
Owner:ONCOMAX ACQUISITION CORP

Extraction device for breast cancer tsRNA marker detection reagent production

PendingCN114471326ARealize free switchingImprove smooth performanceRotary stirring mixersTransportation and packagingMechanical engineeringMedical treatment
The invention relates to the technical field of medical reagent production, in particular to an extraction device for breast cancer tsRNA marker detection reagent production. An extraction device for breast cancer tsRNA marker detection reagent production comprises a first tank body, a centrifugal power system is arranged on the first tank body, a material collecting unit is arranged on the inner wall of the first tank body, a fixing cover is installed at the top of the inner wall of the first tank body, and a centrifugal unit is arranged at the bottom of the fixing cover; the centrifugal unit comprises a centrifugal barrel; the top of the centrifugal barrel is rotationally connected to the bottom of the fixed cover, and a cavity of the centrifugal barrel is communicated with a cavity of the fixed cover; a material throwing belt is spirally distributed on the outer wall of the centrifugal cylinder, and a plurality of groups of material throwing holes are formed in the material throwing belt at equal intervals; and a first rotating rod is arranged on the central axis in the centrifugal cylinder. The device not only meets the integrated operation of crushing, centrifuging, collecting and precipitating in the extraction work, but also reduces the labor intensity at the same time.
Owner:JIANGSU CANCER HOSPITAL

Methods of treating a tumor

InactiveUS20210292415A1Increased proliferationIncrease PD- expressionPeptide/protein ingredientsImmunoglobulins against cell receptors/antigens/surface-determinantsMelanomaAntiendomysial antibodies
Owner:BRISTOL MYERS SQUIBB CO +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products